Source analysis of whether Venetoclax is an imported drug or a domestic drug

Venetoclax (Venetoclax, also known as venetoclax) is a new type of oral BCL-2 inhibitor, developed by AbbVie (AbbVie) and Roche (Roche), it is the world's first BCL-2 targeted drug approved for the treatment of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Its mechanism of action is to promote tumor cell apoptosis by selectively inhibiting BCL-2 protein, thereby inhibiting tumor growth. In recent years, with the continuous advancement of clinical research, venetoclax has shown good efficacy in the treatment of various hematological tumors and has gradually become one of the important targeted therapeutic drugs in the world.

Currently, the original drug of venetoclax has been officially launched in China and has been included in the National Medical Insurance List. Its indications include the treatment of acute myeloid leukemia patients who are not suitable for intensive chemotherapy in combination with azacitidine or decitabine. Patients can purchase it directly from regular hospital pharmacies in China with a doctor's prescription. The drugs are all imported from original research, and the quality and efficacy are guaranteed. According to the latest price information, the price of 100mg×28 capsules of venetoclax is approximately RMB2000 yuan. Specific medical insurance reimbursement ratios and policies vary from region to region. It is recommended that patients consult the local medical insurance department or hospital pharmacy to obtain more accurate reimbursement information and medication guidance.

In addition to domestic original drugs, some generic versions of venetoclax from Laos and Bangladesh have also appeared on the market. Most of these generic drugs are produced by local qualified pharmaceutical factories. Their ingredients are basically the same as imported original drugs, and their prices are more advantageous. Taking 100mg×120 capsules as an example, the price of generic drugs in Laos and Bangladesh is usually around RMB 1,000, and even smaller packaging prices are around a few hundred yuan, which is much cheaper than the price of domestic original drugs. This is one of the reasons why some patients have chosen to purchase overseas generic drugs through formal cross-border drug purchasing channels in recent years. However, it should be noted that patients should choose reliable channels to ensure the quality and authenticity of medicines.

Taken together, venetoclax is mainly sold in China as imported original drugs. Although its price is relatively high, it has been included in medical insurance, and the actual payment pressure has been alleviated. However, the price of generic drugs produced in countries such as Laos and Bangladesh is lower, which to a certain extent meets the medication needs of some patients with limited economic conditions. Regardless of whether you choose original drugs or generic drugs, they should be used under the guidance of a doctor to avoid stopping the drug or changing the drug on your own, which may lead to a decrease in efficacy or adverse reactions. In addition, it is recommended that when choosing generic drugs, patients must go through regular pharmacies, regular agents or certified cross-border drug purchase platforms to ensure drug safety and efficacy.

Reference materials:https://www.drugs.com/